Genovis announced at the 2018 Annual General Meeting. The company elected, Lena Söderström and Peter Hein, will be elected, while Jacob Engellau will leave the Board. Lena Söderström has been CEO of Senzime AB (publ) since 2013 and was previously CEO of Isconova and Kibion; prior to that she held various positions at Fresenius Kabi and Pharmacia. Lena has extensive Board experience and is currently on the Board of Directors of Uppsala University Holding AB and SLU Holding AB. Peter Hein has extensive experience from leading positions in the life science industry. He has been CFO at Q-Med and Biolipox (Orexo). He has also served as CFO and CEO of Granngården. His background is in business and finance, including at Ericsson and Swedish Match in Switzerland. For the past two years Peter has worked as a consultant and interim CFO for a couple of small biotech companies.